Global Cord Blood Corpora...

NYSE: CO · Real-Time Price · USD
2.99
0.77 (34.68%)
At close: Jun 09, 2023, 3:43 PM

Global Cord Blood Income Statement

Financials in CNY. Fiscal year is April - March.
Fiscal Year FY 2022 FY 2021
Period Ending Mar 31, 2022 Mar 31, 2021
Revenue
1.24B 1.16B
Cost of Revenue
183.31M 178.95M
Gross Profit
1.06B 980.69M
Operating Income
608.87M 544.87M
Interest Income
32.61M 30.9M
Pretax Income
627.84M 610.75M
Net Income
501.06M 508.25M
Selling & General & Admin
428.79M 412.05M
Research & Development
22.3M 23.77M
Other Expenses
n/a n/a
Operating Expenses
451.08M 435.82M
Interest Expense
n/a n/a
Selling & Marketing Expenses
241.72M 237.69M
Cost & Expenses
634.39M 614.77M
Income Tax Expense
118.35M 94.55M
Shares Outstanding (Basic)
121.55M 121.55M
Shares Outstanding (Diluted)
121.55M 121.55M
EPS (Basic)
4.12 4.18
EPS (Diluted)
4.12 4.18
EBITDA
628.78M 518.05M
EBIT
608.87M 544.87M
Depreciation & Amortization
47.92M 49.09M